Epic Pharma
As of the edition of 20 October 2026, Epic Pharma runs 12 drugs, 12 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 12 |
| Total | 12 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Lidocaine | none listed | 2 |
| Hydrocortisone | none listed | 5 |
| Furosemide | none listed | 2 |
| Heparin | none listed | 5 |
| Isoniazid | none listed | 0 |
| Pilocarpine | none listed | 2 |
| Heparin sodium | none listed | 3 |
| Aminocaproic acid | none listed | 1 |
| Benztropine | none listed | 1 |
| Hydroxyprogesterone caproate | none listed | 1 |
| Hydrocortisone acetate | none listed | 2 |
| Capreomycin | none listed | 0 |
A route B row is one company at one target.